Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis.

Journal of virological methods - 1 Oct 2017

Neto Mário F, Butzler Matthew A, Reed Jennifer L, Rui Xiang, Fisher Mark J, Kelso David M, McFall Sally M

Abstract excerpt

The lack of hepatitis C virus (HCV) diagnostic tests designed for use in decentralized settings is a major obstacle for providing access to treatment and prevention services particularly in low and middle income countries. Here we describe the development and validation of two building blocks of the HCV Quant Assay, a test in development for point-of-care use: 1) an RT-qPCR assay with noncompetitive internal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Point-of-Care Systems

Share to Reagent Kits, Diagnostic

Share to Real-Time Polymerase Chain Reaction

Share to Sensitivity and Specificity

Share to Serologic Tests

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 28673855
DOI: 10.1016/j.jviromet.2017.06.016
PMCID: PMC5592153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis.PMID 28673855Read ↗

Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.Semantic proximity Read ↗

Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System.Semantic proximity Read ↗

Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia.Semantic proximity Read ↗

Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA.Semantic proximity Read ↗

The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA.Semantic proximity Read ↗

Development of RT-LAMP assay for variants of HCV in Pakistan.Semantic proximity Read ↗

HDV RNA assays: Performance characteristics, clinical utility, and challengesSemantic proximity Read ↗

Evaluation of the Point of Care Molecular Diagnostic Genedrive HCV ID Kit for the detection of HCV RNA in clinical samples.Semantic proximity Read ↗

Performance evaluation of the Aptima® HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay.Semantic proximity Read ↗

A new system to measure and compare hepatitis C virus replication capacity using full-length, replication competent viruses.Semantic proximity Read ↗

Performance characteristics of a quantitative, homogeneous TaqMan RT-PCR test for HCV RNA.Semantic proximity Read ↗

Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.